Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Recurrent Follicular Lymphoma

The reemergence of follicular lymphoma after a period of remission.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Combined treatment with lenalidomide/rituximab resulted in better clinical response in patients with recurrent follicular… Expand
Is this relevant?
2012
2012
8000 Background: Lenalidomide (L) and rituximab (R) are active as single agents in follicular (FL) and other B-cell lymphomas… Expand
Is this relevant?
2012
2012
Thirty-five consecutive patients with follicular lymphoma (FL) receiving SCT at our institution between January 2000 and December… Expand
  • table 1
  • figure 1
Is this relevant?
2010
2010
The combination of bortezomib and rituximab was evaluated in patients with mantle cell lymphoma (MCL), follicular lymphoma (FL… Expand
Is this relevant?
2010
2010
BACKGROUND The impact of active surveillance, comprising annual computed tomography scanning and bone marrow biopsies, in the… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2007
2007
BACKGROUND The current study was conducted to asses the safety profile and clinical activity of rituximab in combination with… Expand
  • figure 1
  • table 2
  • table 1
  • figure 2
  • table 4
Is this relevant?
2006
2004
2004
A 59-year-old woman was admitted to our hospital because of recurrent follicular lymphoma (FL). Colonoscopic examination revealed… Expand
Is this relevant?
Highly Cited
1995
Highly Cited
1995
PURPOSE To examine outcome of treatment for patients with recurrent follicular lymphoma. PATIENTS AND METHODS Two hundred… Expand
Is this relevant?
Highly Cited
1994
Highly Cited
1994
PURPOSE To assess myeloablative therapy with autologous bone marrow transplantation (ABMT) in younger patients with follicular… Expand
Is this relevant?